Joseph Milum, MD
Family Medicine · Louisville, KYNPI 1497759138
Payments from drug & device makers
Across 84 payments — averaging $19.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organogenesis Inc.$458
- Smith+Nephew$393
- Kerecis Limited$139
- Mimedx Group, Inc.$88
- Legacy Ortho LLC$78
- Polymedics Innovations Inc.$69
- plus $410 from 13 others
What the payments were for
- Food & beverage$1,635100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organogenesis Inc. | 24 | $458 |
| Smith+Nephew | 22 | $393 |
| Kerecis Limited | 9 | $139 |
| Mimedx Group, Inc. | 3 | $88 |
| Legacy Ortho LLC | 2 | $78 |
| Polymedics Innovations Inc. | 1 | $69 |
| Celularity Inc. | 3 | $63 |
| Paratek Pharmaceuticals, Inc. | 3 | $54 |
| KCI USA, Inc. | 3 | $54 |
| Integra Lifesciences Corporation | 3 | $47 |
| Convatec Inc. | 2 | $39 |
| Aroa Biosurgery Incorporated | 2 | $27 |
| Solventum Corporation | 1 | $25 |
| Bsn Medical Inc | 1 | $23 |
| Biotissue Holdings Inc. | 1 | $20 |
| Reapplix Inc. | 1 | $18 |
| Reprise Biomedical, Inc. | 1 | $14 |
| Melinta Therapeutics, LLC | 1 | $14 |
| Medela LLC | 1 | $13 |
How this compares
$1,635 in reported general payments places this provider in the 65th percentile of 1,559 family medicine providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gentamicin Sulfate | 35 | $1,550 |
| Doxycycline Monohydrate | 95 | $1,129 |
| CefuroximeCefuroxime Axetil | 30 | $915 |
| Silver Sulfadiazine | 64 | $761 |
| Mupirocin | 87 | $662 |
| SsdSilver Sulfadiazine | 23 | $272 |
| Cephalexin | 32 | $249 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 15 | $221 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 21 | $204 |
| Nystatin | 13 | $168 |
| Levofloxacin | 38 | $133 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 31 | $131 |
| Amoxicillin | 23 | $113 |
| Triamcinolone Acetonide | 20 | $54 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Louisville
- Christopher RhyneLouisville$1M
- Michael LovelaceLouisville$244K
- Suraj GathaniLouisville$69K
- Mandy WhittLouisville$38K
- Michael PendletonLouisville$29K
- Rajanbhai AminLouisville$26K
- James WrightLouisville$18K
- Rosenberg ReyesLouisville$18K
- Dennis GrayLouisville$14K
- Vincent LangLouisville$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.